Thoracoscopic lobectomy for benign disease--a single centre study on 64 cases

Area of Science:

• Thoracic Surgery
• Minimally Invasive Procedures
• Pulmonary Medicine

Background:

• Chronic lung infections are a primary indication for lobectomy in benign pulmonary disease.
• Inflammatory changes in chronic lung disease can make lobectomy technically challenging.
• The efficacy of thoracoscopic lobectomy (TL) for these conditions requires further definition.

Purpose of the Study:

• To evaluate the safety and outcomes of thoracoscopic lobectomy (TL) versus open lobectomy (OL) for benign pulmonary disease.
• To compare operative time, blood loss, drainage duration, and hospital stay between TL and OL.
• To assess the feasibility of TL in complex cases involving chronic inflammation.

Main Methods:

• Retrospective analysis of 117 lobectomies for benign disease (64 TL, 53 OL) performed between 1992 and June 1999.
• Comparison of patient data between the TL and OL groups.
• Nonparametric statistical analysis due to non-normally distributed data.

Main Results:

• Thoracoscopic lobectomy (TL) demonstrated significantly decreased operation times over the study period (2.5h to 1.5h).
• TL showed a trend towards less blood loss compared to open lobectomy (OL).
• Drainage time and hospital stay did not differ significantly between TL and OL; conversion rate to thoracotomy was low (12 cases due to adhesions).

Conclusions:

• Thoracoscopic lobectomy (TL) is a safe and effective option for selected patients with chronic inflammatory lung disease, especially bronchiectasis.
• The technique's efficiency has improved, with significantly reduced operative times.
• TL offers a viable minimally invasive alternative to open lobectomy (OL) in these challenging cases.